Skip to main content
Log in

The Mode of Action of Cyclosporin

  • Original Research Article
  • Published:
Drug Investigation Aims and scope Submit manuscript

Summary

To try to explain the wide therapeutic range of cyclosporin A, we examined its effects on physiological functions of skin and responses to immunological and inflammatory stimuli during and before or after administration of 5 mg/kg/day of cyclosporin A in the treatment of various skin diseases.

Pilocarpine-stimulated, sweat rate (10 patients), sebum excretion rate (10), scalp hair growth rate (8) and epidermal proliferation in response to tape-stripping (7) were not affected by cyclosporin A; nail growth rate was unaltered in patients without psoriasis (12), but was significantly slowed by treatment in patients with psoriasis (7) who had abnormally rapid growth before treatment.

Induction of cell-mediated sensitisation to 2,4-dinitrochlorobenzene (DNCB) was inhibited by cyclosporin A treatment (22 patients), but 7 patients sensitised to DNCB before cyclosporin treatment reacted normally to DNCB challenge during treatment. The immediate hypersensitivity response to intradermal house dust mite antigen was increased during treatment in 8 patients with atopy.

Weal responses to histamine (9 patients) and compound 48/80 (12), the 24 hour erythemal response to ultraviolet B (UVB) irradiation (10) and the inflammatory response to topical leukotriene B4 (16) were not affected, but cyclosporin A produced a striking inhibition of anthralin inflammation (21).

Since the methods we used will have detected all but minor changes, we conclude that cyclosporin A has no gross physiological effects on the skin and is not cytostatic; hypertrichosis must be due to a prolonged hair cycle. Secondly, cyclosporin A (a) impairs induction of cell-mediated sensitisation in doses which permit some continued expression, but (b) increases immediate hypersensitivity. Thirdly, cyclosporin A has no general anti-inflammatory effect, but we have found a novel and specific inhibitory effect on anthralin inflammation, the mechanism of which may underlie some of its therapeutic effects. The therapeutic effect of cyclosporin A may not be due solely to its immune effects, and other activities such as the anti-inflammatory effect we found need further exploration.

This is a preview of subscription content, log in via an institution to check access.

Access this article

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Similar content being viewed by others

References

  • Amlott PL, Hayes AE, Gray D, Gordon-Smith E, Humphrey JH. Human immune responses in vivo to protein (KLH) and polysaccharide (DNP-Ficoll) neoantigens: normal subjects compared with bone marrow transplant patients on cyclosporin. Clinical and Experimental Immunology 64: 125–135, 1986

    Google Scholar 

  • Barthelemy H, Thivolet J, Cambazard F, Benbdelac A, Mauduit G, et al. La ciclosporine dans le traitement de la pemphigoide bulleuse. Annals of Dermatology and Venereology 113: 309–313, 1986

    CAS  Google Scholar 

  • Bencini PL, Montagnino G, Crosti C, Sala F, De Vecchi A. Acne in a kidney transplant patient treated with cyclosporin A. British Journal of Dermatology 115: 396–397, 1986

    Article  Google Scholar 

  • Bendtzen K, Trede N, Andersen V, Benxiden G. Cyclosporin for polymyositis. Lancet 2: 792–793, 1984

    Article  Google Scholar 

  • Bennett WM, Pulliam JP. Cyclosporin nephrotoxicity. Annals of Internal Medicine 305: 267–273, 1983

    Google Scholar 

  • Bennett WM, Elzinga L, Kelley V. Pathophysiology of cyclosporin nephrotoxicity: role of eicosanoids. Transplantation Proceedings 20(Suppl. 3): 628–633, 1988.

    PubMed  CAS  Google Scholar 

  • Calne RY, Rolles K, White DG, Thiru S, Evans DB, et al. Cyclosporin A initially as the only immunosuppressant in 34 recipients of cadaveric transplants: 32 kidneys, 2 pancreases, and 2 livers. Lancet 2: 1033–1036, 1979

    Article  PubMed  CAS  Google Scholar 

  • Camp RA, Russell Jones R, Brain S, Woollard P, Greaves M. Production of intraepidermal abscesses by topical application of leukotriene B4. Journal of Investigative Dermatology 82: 202–204, 1984.

    Article  PubMed  CAS  Google Scholar 

  • Chen SS. Cyclosporin A acts as a potent co-stimulator in up-regulation of IgE antibody synthesis and expression of receptor of IgE. Transplantation Proceedings 20(Suppl. 2): 92–102, 1988

    PubMed  CAS  Google Scholar 

  • Cook J, Shuster S. Histamine weal formation and absorption in man. British Journal of Pharmacology 69: 579–585, 1980

    Article  PubMed  CAS  Google Scholar 

  • Crounse RG, van Scott ES. Changes in scalp hair roots as a measure of toxicity for cancer chemotherapeutic agents. Journal of Investigative Dermatology 35: 83–90, 1960

    PubMed  CAS  Google Scholar 

  • Curley RK, Macfarlane AW, Vickers CF. Pyoderma gangrenosum treated with cyclosporin A. British Journal of Dermatology 113: 601–604, 1985

    Article  PubMed  CAS  Google Scholar 

  • Dawber R. Fingernail growth in normal and psoriatic patients. British Journal of Dermatology 82: 454–471, 1970

    Article  PubMed  CAS  Google Scholar 

  • Dawber R. The nails. In Rook, et al. (Eds) Textbook of dermatology, 4th ed., Vol. 3, pp. 2039–2073, Blackwell Scientific Publication, Oxford, 1986

    Google Scholar 

  • Diffey BL, Oliver RJ, Farr PM. A portable instrument for quantifying erythema induced by ultraviolet radiation. British Journal of Dermatology 111: 663–672, 1984

    Article  PubMed  CAS  Google Scholar 

  • Esa AH, Paxman DG, Noga SJ, Hess AD. Sensitivity of monocyte subpopulations to cyclosporin A: arachidonate metabolism and in vitro antigen presentation. Transplantation Proceedings 20(Suppl. 2): 80–86, 1988

    PubMed  CAS  Google Scholar 

  • Farr PM, Diffey BL. The erythemal response of human skin to ultraviolet radiation. British Journal of Dermatology 113: 65–75, 1985

    Article  PubMed  CAS  Google Scholar 

  • Farr PM, Diffey BL. A quantitative study of the effect of topical indomethacin on cutaneous erythema induced by UVB and UVC radiation. British Journal of Dermatology 115: 453–466, 1986

    Article  PubMed  CAS  Google Scholar 

  • Farr PM, Diffey BL, Humphreys F. A quantitative study of the effect of terfenadine on cutaneous erythema induced by UVB and UVC irradiation. Journal of Investigative Dermatology 87: 771–774, 1986

    Article  PubMed  CAS  Google Scholar 

  • Finnen MJ, Lawrence CM, Shuster S. Inhibition of dithranol inflammation by free radical scavengers. Lancet 2: 1129–1130, 1984

    Article  PubMed  CAS  Google Scholar 

  • Harper JI, Keat JCS, Staughton RCD. Cyclosporin A for psoriasis. Lancet 2: 981–982, 1984

    Article  PubMed  CAS  Google Scholar 

  • Hess AD, Esa AH, Colombani PM. Mechanisms of action of cyclosporine: effect on cells of the immune system and subcellular events in T cell activation. Transplantation Proceedings 20(Suppl. 2): 29–40, 1988

    PubMed  CAS  Google Scholar 

  • Humphreys F, Shuster S. The effect of nedocromil on weal reactions in human skin. British Journal of Clinical Pharmacology 24: 405–408, 1987

    Article  PubMed  CAS  Google Scholar 

  • Humphreys F, Krause LB, Shuster S. The effects of astemizole and indomethacin on weal and flare reactions to histamine, 48/80, and house dust mite antigen. British Journal of Dermatology 116: 435, 1987

    Google Scholar 

  • Jones HF, Lewis CF, McMarlin SL. Allergic contact sensitivity in atopic dermatitis. Archives of Dermatology 107: 217–222, 1973

    Article  PubMed  CAS  Google Scholar 

  • Katakkar SB. Cyclosporin and pure red cell aplasia. Transplantation Proceedings 20(Suppl. 4): 314–316, 1988

    PubMed  CAS  Google Scholar 

  • Kelsey PR, Schofield KP, Geary CG. Refractory idiopathic thrombocytopenic purpura (ITP) treated with cyclosporin. British Journal of Haematology 60: 197–198, 1985

    Article  PubMed  CAS  Google Scholar 

  • Kragballe K, Ternowitz T. Treatment with cyclosporin A in psoriasis results in inhibition of the inflammatory response to intradermal injections of leukotriene B4 and CsA. Skin Pharmacology 1: 68–69, 1988.

    Google Scholar 

  • Lawrence CM, Shuster S. Comparison of ultrasound and caliper measurements of normal and inflamed skin thickness. British Journal of Dermatology 112: 195–200, 1985a

    Article  PubMed  CAS  Google Scholar 

  • Lawrence CM, Shuster S. Mechanism of anthralin inflammation, I; dissociation of response to clobetasol and indomethacin. British Journal of Dermatology 113: 107–115, 1985b

    Article  PubMed  CAS  Google Scholar 

  • Lawrence CM, Shuster S. Effect of arachidonic acid on anthralin inflammation. British Journal of Clinical Pharmacology 24: 125–131, 1987

    Article  PubMed  CAS  Google Scholar 

  • Lookingbill DP, Cunliffe WJ. A direct gravimetric method for measuring sebum excretion rate. British Journal of Dermatology 114: 75–81, 1986

    Article  PubMed  CAS  Google Scholar 

  • Marks J. Psoriasis. British Medical Journal 293: 509, 1986

    Article  PubMed  CAS  Google Scholar 

  • Miller RA, Shen JY, Rea TH, Harnisch JP. Treatment of chronic erythema nodosum leprosum with cyclosporin A produces clinical and immunohistologic remission. International Journal of Leprosy and Other Mycobacterial Diseases 55: 441–449, 1987

    PubMed  CAS  Google Scholar 

  • Mitchell EB, Crow J, Chapman MD, Jouhal SS, Pope FM, Platts-Mills TAE. Basophils in allergen-induced patch test sites in atopic dermatitis. Lancet 1: 127–130, 1982

    Article  PubMed  CAS  Google Scholar 

  • Mueller W, Hermann B. Cyclosporin A for psoriasis. New England Journal of Medicine 301: 555, 1979

    PubMed  CAS  Google Scholar 

  • Norris PG, Schofield O, Camp RDR. A study of the role of house dust mite in atopic dermatitis. British Journal of Dermatology 118: 435–440, 1988

    Article  PubMed  CAS  Google Scholar 

  • Nussenblatt RB, Palestine AG, Rook AH, Sher I, Wacken WB, et al. Treatment of ocular inflammatory diseases with cyclosporin A. Lancet 2: 235–238, 1983

    Article  PubMed  CAS  Google Scholar 

  • Palestine AG, Nussenblatt RB, Chan CC. Side-effects of cyclosporin in patients not undergoing transplantation. American Journal of Medicine 77: 652–656, 1984

    Article  PubMed  CAS  Google Scholar 

  • Ponticelli C, Rivolta E. Cyclosporine in nephrotic syndrome. Transplantation Proceedings 20(Suppl. 4): 253–258, 1988

    PubMed  CAS  Google Scholar 

  • Ralfs I, Dawber R, Ryan T, Duffill M, Wright NA. The kinetics of metaphase arrest in human psoriatic epidermis: an examination of optimal experimental conditions for determining the birth rate. British Journal of Dermatology 104: 231–242, 1981

    Article  PubMed  CAS  Google Scholar 

  • Rees J, Shuster S. Pubertal induction of sweat gland activity. Clinical Science 60: 689–692, 1981

    PubMed  CAS  Google Scholar 

  • Rogge JL, Hanifin JF. Immunodeficiencies in severe atopic eczema. Archives of Dermatology 112: 1391–1396, 1976

    Article  PubMed  CAS  Google Scholar 

  • Selleri C, Catalano L, Alfinito F, De Rosa G, Vaglio S, et al. Cyclosporin A in adult onset cyclic neutropenia. British Journal of Haematology 68: 137–138, 1988

    Article  PubMed  CAS  Google Scholar 

  • Seymour RA, Smith DG, Roghers SR. The comparative effects of azathioprine and cyclosporin A on some gingival health parameters of renal transplant recipients. Journal of Clinical Periodontology 14: 610–613, 1987

    Article  PubMed  CAS  Google Scholar 

  • Shuster S. Cyclosporin in dermatology. Transplantation Proceedings 20(Suppl. 4): 19–22, 1988.

    PubMed  CAS  Google Scholar 

  • Van Rijthoven AWAM, Dijkman BAC, Goei Thè HS, Henery J, Montnor Becker ZLMB, et al. Cyclosporin A treatment for rheumatoid arthritis: a placebo-controlled, double blind, multicentre study. Annals of Rheumatic Diseases 45: 726–730, 1986

    Article  Google Scholar 

  • Van Joost T, Stolz E, Heule F. Efficacy of low-dose cyclosporine in severe atopic skin disease. Archives of Dermatology 123: 166–167, 1987

    Article  PubMed  Google Scholar 

  • Van der Heyden AAPAM, van Oers MHJ, Cornelissen P, Yons SL, Wimink JM, et al. The influence of cyclosporin A treatment on immune response in vitro and in vivo in kidney transplant recipients. Transplantation Proceedings 20(Suppl. 2): 190–195, 1988

    PubMed  Google Scholar 

  • White SI, Friedmann PS, Moss C, Simpson JM. The effect of altering area of application and dose per unit area on sensitization by DNCB. British Journal of Dermatology 115: 663–668, 1986

    Article  PubMed  CAS  Google Scholar 

Download references

Author information

Authors and Affiliations

Authors

Rights and permissions

Reprints and permissions

About this article

Cite this article

Munro, C.S., Higgins, E.M., Ramsay, B. et al. The Mode of Action of Cyclosporin. Drug Invest 2, 1–9 (1990). https://doi.org/10.1007/BF03259395

Download citation

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1007/BF03259395

Keywords

Navigation